Biotie Therapies announced that it has signed a Collaborative Research and Development Agreement with the National Institute on Drug Abuse (NIDA) at the US National Institutes of Health.Under the agreement, NIDA and Biotie will investigate the safety and efficacy of Biotie's nepicastat (SY ... more
To use all functions of this page, please activate cookies in your browser.
